747P Phase I study of SAR444245 (SAR'245) as monotherapy (mono) and combined with pembrolizumab (pembro) or cetuximab (cetux) in patients (pts) with advanced solid tumors. - Falchook, G.S.; Fu, S.; Lemech, C.; Mckean, M.A.; Azad, A.A.; Gan, H.K.; Sommerhalder, D.; Wang, J.S.; Tan, T.J.Y.; Chee, C.E.; Barve, M.; Moser, J.; et al. (Annals of Oncology, 2022)